JANE POESCHEL: Open Payments
NPI 1316907231 · DURAND, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 50 payments from 11 companies in 2025. Trend: 2023 $1,005 · 2024 $931 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $339 |
| Novo Nordisk Inc | 11 | $160 |
| Amgen Inc. | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| PFIZER INC. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: QULIPTA, VRAYLAR, Rybelsus, EVENITY, MOUNJARO, LINZESS, Ozempic, CAPLYTA.
Industry payments across WI — which companies pay providers there.
